These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30040864)

  • 21. Correction: Krüppel-like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression.
    Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW
    PLoS One; 2016; 11(4):e0154168. PubMed ID: 27123593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction: Hepatitis C Virus Core Protein Down-Regulates p21Waf1/Cip1 and Inhibits Curcumin-Induced Apoptosis through MicroRNA-345 Targeting in Human Hepatoma Cells.
    Shiu TY; Huang SM; Shih YL; Chu HC; Chang WK; Hsieh TY
    PLoS One; 2017; 12(7):e0181299. PubMed ID: 28686748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction: Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.
    PLOS ONE Staff
    PLoS One; 2021; 16(5):e0251539. PubMed ID: 33956887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review.
    Yang B; Liang J; Qu Z; Yang F; Liao Z; Gou H
    PLoS One; 2020; 15(3):e0230369. PubMed ID: 32142539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction: Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus.
    Helle F; Brochot E; Fournier C; Descamps V; Izquierdo L; Hoffmann TW; Morel V; Herpe YE; Bengrine A; Belouzard S; Wychowski C; Dubuisson J; Francois C; Regimbeau JM; Castelain S; Duverlie G
    PLoS One; 2019; 14(9):e0223022. PubMed ID: 31536586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction: Association of Sjögren's Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    Yeh CC; Wang WC; Wu CS; Sung FC; Su CT; Shieh YH; Chang SN; Su FH
    PLoS One; 2016; 11(10):e0164911. PubMed ID: 27749926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
    PLOS ONE Staff
    PLoS One; 2020; 15(6):e0235580. PubMed ID: 32584902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.
    PLOS ONE Staff
    PLoS One; 2021; 16(4):e0250185. PubMed ID: 33831111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
    Giannelli G; Santoro A; Kelley RK; Gane E; Paradis V; Cleverly A; Smith C; Estrem ST; Man M; Wang S; Lahn MM; Raymond E; Benhadji KA; Faivre S
    PLoS One; 2021; 16(6):e0253671. PubMed ID: 34138968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma.
    Wu J; Shen SL; Chen B; Nie J; Peng BG
    PLoS One; 2022; 17(3):e0265938. PubMed ID: 35320325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
    Facente SN; Grebe E; Burk K; Morris MD; Murphy EL; Mirzazadeh A; Smith AA; Sanchez MA; Evans JL; Nishimura A; Raymond HF;
    PLoS One; 2018; 13(7):e0200866. PubMed ID: 30001389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction: Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.
    Capileno YA; Van den Bergh R; Donchuk D; Hinderaker SG; Hamid S; Auat R; Khalid GG; Fatima R; Yaqoob A; Van Overloop C
    PLoS One; 2017; 12(6):e0180286. PubMed ID: 28640872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis.
    Greenaway C; Ma AT; Kloda LA; Klein M; Cnossen S; Schwarzer G; Shrier I
    PLoS One; 2015; 10(12):e0144567. PubMed ID: 26650678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction: Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis.
    She Y; Nong X; Zhang M; Wang M
    PLoS One; 2019; 14(6):e0217659. PubMed ID: 31220104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
    Gambato M; Caro-Pérez N; González P; Cañete N; Mariño Z; Lens S; Bonacci M; Bartres C; Sánchez-Tapias JM; Carrión JA; Forns X; Juan M; Pérez-Del-Pulgar S; Londoño MC
    PLoS One; 2017; 12(1):e0170913. PubMed ID: 28107531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
    Buti M; Manzano ML; Morillas RM; García-Retortillo M; Martín L; Prieto M; Gutiérrez ML; Suárez E; Rubio MG; López J; Castillo P; Rodríguez M; Zozaya JM; Simón MA; Morano LE; Calleja JL; Yébenes M; Esteban R
    PLoS One; 2018; 13(6):e0199926. PubMed ID: 29940039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: Chronic Hepatitis C: Conspectus of immunological events in the course of fibrosis evolution.
    Baskic D; Vukovic V; Popovic S; Jovanovic D; Mitrovic S; Djurdjevic P; Avramovic D; Arsovic A; Bankovic D; Cukic J; Mijailovic Z
    PLoS One; 2019; 14(8):e0221142. PubMed ID: 31393958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: Survival from alcoholic hepatitis has not improved over time.
    Hughes E; Hopkins LJ; Parker R
    PLoS One; 2018; 13(4):e0195857. PubMed ID: 29634763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction: Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study.
    Kalman RS; Stawarz A; Nunes D; Zhang D; Dela Cruz MA; Mohanty A; Subramanian H; Backman V; Roy HK
    PLoS One; 2018; 13(7):e0201500. PubMed ID: 30040862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction: The Increasing Burden of Imported Chronic Hepatitis B - United States, 1974-2008.
    Mitchell T; Armstrong GL; Hu DJ; Wasley A; Painter JA
    PLoS One; 2013; 8(3):. PubMed ID: 29294478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.